Search

everythinglearnresearchcommunity

for

Search:↓

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Finasteride reduces hair growth better, but spironolactone has more side effects.

The circadian clock influences the behavior and regeneration of stem cells in the body.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

People with hair loss, especially those with certain types, have lower zinc levels, and zinc supplements might help.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Dermal exosomes with miR-218-5p boost hair growth by controlling β-catenin signaling.

Human hair follicles can make and process prostaglandins, which may affect hair growth.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Wnt1a-conditioned medium from stem cells helps activate cells important for hair growth and can promote hair regrowth.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

SHBG may be a useful early indicator and treatment target for PCOS.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

All three treatments reduce hirsutism, but spironolactone works best long-term.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.